Delve Bio的动态

The intricacies of immunomodulation in clinical trials can be complex, but our latest issue of The Altascientist breaks them down for you, including the standard classes of immunomodulators, advanced bioanalytical methods, and case studies with practical insights. Whether you focus on PK/PD studies or assess safety, we provide the strategies you need for reliable, actionable results. Read it now: https://lnkd.in/grA_ep5F #DrugDevelopment #ClinicalTrials #Bioanalysis

One more day until our webinar with Panalgo where we will look at the scientific and operational details behind study replication, using vitiligo and alopecia areata as an example. Topics covered: ?? Vitiligo and alopecia areata landscapes including prevalence, current treatment options, treatments in development, co-occurrence of the two conditions, other comorbid conditions and impact on patients’ quality of life ?? Study replication and treatment pathway visualization in Panalgo’s IHD platform ?? Richness of OM1 and multi-modal data Register now: https://bit.ly/4asTtFc

?? Now at ASCRO, Uppsala: Martin Bergstrand explains the possibilities of Model Informed Drug Development, how it can reduce time to market, cost, size of study population and increase probability of success in dose selection, formulation and route of administration among other things, to an engaged audience from different Clinical Research Organizations, (CRO). ?? And a tip: There are still (very) few seats left to a workshop on the topic, “An introduction to probabilistic decision support in drug development”, in Rome during PAGE, led by Martin, our CEO Peter Milligan, Chief statistician Richard Anziano and Senior Consultant Giovanni Smania. #cro #lifesciences #biosimulation #biotech

?? There's still time to contribute to our collection "The Potential of Transferrin as a Drug Target and Drug Delivery System'' ?? led by the team: Dr. Nermi Parrow, Dr. Mallikarjuna Rao Pichika, Dr. Sidharth Chopra and Dr. Patricia Carrilho. ?? Check out the details here https://lnkd.in/dTSATNPG This Research Topic is committed to extending our understanding of Transferrin as a two-pronged weapon: as a drug target and an efficient drug delivery system. Link here to participate ?? https://lnkd.in/dmUbE5ki Manuscript Submission Deadline 15 March 2024 #Transferrin #DrugDelivery #ironmetabolism #metabolicpathways #translationalpharmacology

Following the [? radioactive ? ] bread crumbs: Yesterday I posted about "The ɑ-emitting radioisotope’s rapid decay has?logistical drawbacks, but its supply could beat actinium-225’s on scale" ( https://lnkd.in/gDh56sEx ) Karen Tkach Tuzman continues on that theme with this next report: "Decisions about manufacturing and distribution could be make-or-break for drug developers producing their own lead-212" Why is this analysis worth diving into? What are you gonna take away from reading these reports? ?? Guide strategic decisions ?? Understand distribution challenges and solutions ?? Offers comprehensive analysis of manufacturing methods PLUS, you'll hear insights directly from thought-leaders like: Julien Dodet - CEO of Orano Med LLC Emanuele Ostuni - CEO of ARTbio Inc. Julien Torgue - CSO of Orano Med LLC Patrick Amstutz - CEO of Molecular Partners AG Simon Puttick - CSO of AdvanCell Isotopes Pty. Ltd. Roy Larsen - Co-founder of ARTbio Inc. Andrew Adamovich - CEO of AdvanCell Isotopes Pty. Ltd. Thijs Spoor - CEO of Perspective Therapeutics Inc. Links to the articles and analysis above ?? in the Comments below ??

Kinetics in drug discovery - really useful review of how to measure kinetics efficiently in the early stages of drug discovery. Thanks Claire!

Stay in the loop! Explore how LC–MS, LBA and hybrid assays are currently being used to support clinical trials from a bioanalytical perspective, and their advantages and drawbacks in our upcoming panel discussion! Register now >>> https://hubs.ly/Q02KcT8_0

Discover the Integrated Bioanalytical Strategy for LNP-mRNA Based Products and unlock insights into the latest advancements and bioanalytical techniques. Led by Dr. Nan Jia, this session will delve into critical regulatory guidelines, case studies, and innovative solutions for bioanalysis. https://hubs.li/Q02Qt9Q10

At #Domainex we are always searching the literature to keep on top of the latest developments. In the latest edition of our "Medicinal Chemistry in Review" blog series, the focus was on a paper from Genentech which discloses the discovery of GNE7599, a VHL ligand with improved potency and cellular permeability and good oral bioavailability. https://lnkd.in/enp8JRFj We hope you enjoy reading it. #DrugDiscovery #MedChem

Thoughts on this? >> Cycle makes another offer for Vanda; Ocean Biomedical, Molecure ink new deal >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #productmarketing #pharma #pharmaceutical #biotech